Cheng Andrew bought AKRO
October 8, 2025 · Form 4 insider transaction
Cheng Andrew bought 52,212 shares of Akero Therapeutics, Inc. at $0.61 per share, a transaction worth $32.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
52,212
Price
$0.61
Total value
$32.1K
InsiderCheng Andrew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 8, 2025
Filing dateOctober 9, 2025
Shares owned after526,114
OwnershipDirect
10b5-1 planNo
AmendedNo